Evaluation of Nitrogen-Doped Adsorbents Based on Reduced Graphene Oxide as Platforms for CO2 Capture
Matheus Ribeiro,
Isabela Bessa,
Aline da Silva
et al.
Abstract:CO2 emissions into the atmosphere have been rapidly rising due to human activities, resulting in the escalation of global warming. To mitigate climate change, it is imperative to develop materials for CO2 capture with high CO2 capacity and low production costs. Herein, we developed a facile method to obtain adsorbents based on reduced graphene oxide (rGO) sheets, NrGO(1 - X)700, where X represents the mass of diethylenetriamine (DETA) (X = 1, 2 and 4 g) used in the preparation. The materials NrGO(1 - 1)700, Nr… Show more
“…Sundar’s group transitioned from using carbon nanotubes (CNT) to graphene oxide (Gr) because the production process for Gr is simpler and more scalable than that for CNT. , Additionally, graphene sheets offer a theoretical surface area of ca. 2630 m 2 g –1 , , which can enhance drug loading capacity.…”
Section: Inorganic
Materials To Treat Leishmaniasismentioning
Leishmaniasis, a critical Neglected Tropical Disease caused by Leishmania protozoa, represents a significant global health risk, particularly in resource-limited regions. Conventional treatments are effective but suffer from serious limitations, such as toxicity, prolonged treatment courses, and rising drug resistance. Herein, we highlight the potential of inorganic nanomaterials as an innovative approach to enhance Leishmaniasis therapy, aligning with the One Health concept by considering these treatments' environmental, veterinary, and public health impacts. By leveraging the adjustable properties of these nanomaterials�including size, shape, and surface charge, tailored treatments for various diseases can be developed that are less harmful to the environment and nontarget species. We review recent advances in metal-, oxide-, and carbon-based nanomaterials for combating Leishmaniasis, examining their mechanisms of action and their dual use as standalone treatments or drug delivery systems. Our analysis highlights a promising yet underexplored frontier in employing these materials for more holistic and effective disease management.
“…Sundar’s group transitioned from using carbon nanotubes (CNT) to graphene oxide (Gr) because the production process for Gr is simpler and more scalable than that for CNT. , Additionally, graphene sheets offer a theoretical surface area of ca. 2630 m 2 g –1 , , which can enhance drug loading capacity.…”
Section: Inorganic
Materials To Treat Leishmaniasismentioning
Leishmaniasis, a critical Neglected Tropical Disease caused by Leishmania protozoa, represents a significant global health risk, particularly in resource-limited regions. Conventional treatments are effective but suffer from serious limitations, such as toxicity, prolonged treatment courses, and rising drug resistance. Herein, we highlight the potential of inorganic nanomaterials as an innovative approach to enhance Leishmaniasis therapy, aligning with the One Health concept by considering these treatments' environmental, veterinary, and public health impacts. By leveraging the adjustable properties of these nanomaterials�including size, shape, and surface charge, tailored treatments for various diseases can be developed that are less harmful to the environment and nontarget species. We review recent advances in metal-, oxide-, and carbon-based nanomaterials for combating Leishmaniasis, examining their mechanisms of action and their dual use as standalone treatments or drug delivery systems. Our analysis highlights a promising yet underexplored frontier in employing these materials for more holistic and effective disease management.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.